Screener
Xeris Biopharma Holdings, Inc. XERS Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseCurrent.
The source filing: Xeris Biopharma Holdings, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001867096-26-000065
| Assets | June 30, 2026 / (unaudited) | December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $121,747 | $111,042 |
| Trade accounts receivable, net | 58,105 | 51,050 |
| Inventory, net | 80,930 | 68,673 |
| Prepaid expenses and other current assets | 13,975 | 9,548 |
| Total current assets | 274,757 | 240,313 |
| Property and equipment, net | 4,834 | 4,945 |
| Operating lease right-of-use assets | 21,773 | 22,112 |
| Goodwill | 22,859 | 22,859 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Xeris Biopharma Holdings, Inc.'s prepaid & other current?
- Xeris Biopharma Holdings, Inc. (XERS) reported prepaid & other current of $13.98M in Q2 2026.
- How has Xeris Biopharma Holdings, Inc.'s prepaid & other current changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s prepaid & other current increased by 134.4% year-over-year, from $5.96M to $13.98M.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s prepaid & other current?
- Over 5 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s prepaid & other current has grown at a 24.5% compound annual growth rate (CAGR), from $3.2M to $9.55M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Xeris Biopharma Holdings, Inc.'s prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude